Abstract
The independent (1,2) establishment of in vitro culture systems for hemopoietic progenitor cells has allowed the identification of various hormones which regulate blood cell production and differentiation. These glycoproteins, known as colony-stimulating factors (CSFs) were originally purified from the conditioned media of a number of diverse sources, including placenta, tumor cell lines, and peripheral blood mononuclear cells. The factors were initially named according to the predominant colony type their addition produced in cultures of bone marrow cells (3). Currently in the human system, several CSF’s have been defined which act in a hierarchical fashion and which possess varying lineage specificity.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Bradley TR, Metcalf D (1966) The growth of mouse bone marrow cells in vitro. Aust J Exp Biol Med Sci 44: 287
Pluznik DH, Sachs L (1966) The induction of clones of normal mast cells by a substance from conditioned media. Exp Cell Res 43: 553–563
Metcalf D (1984) The Hemopoietic Colony Stimulating Factor. Amsterdam: Elsevier
Stanley ER, Heard PM (1977) Factors regulating macrophage production and growth. Purification and some properties of the colony stimulating factor from medium conditioned by mouse L cells. J Biol Chem 252: 4305–12
Nicola NA, Vadas M (1984) Hemopoietic colony-stimulating factors. Immunol Today 5: 76
Fisher J (1983) Control of Erythropoietin production. Proc Soc Exp Biol Med 173: 289–305
Muraguchi A, Kehnl JH, Longo DL, Wolkman DJ, Smith KA, Fauci AJ (1985) Interleukin 2 receptors on human B cells. Implications for the role of interleukin 2 in human B cell function. J Exp Med 161: 187–97
Moore MAS, Warren DJ, Souza LM (1987) Synergistic interaction between Interleukin 1 and CSF’s in hematopoiesis. In: Gale RP, Golde DW (eds) Recent Advances in Leukemia and Lymphoma, UCLA Symposia on Molecular and Cellular Biology, vol. 61, New York: Alan R. Liss
Zsebo KM, Wypychi J, Yuschenkoff VN, Luff, Hunt P, Dukes PP, Langley RE (1988) Effects on Hematopoietin 1 and Interleukin 1: Activities on Early Hematopoietic cells of the bone marrow. Blood 71: 962
Broxmeyer HE, Cooper S, Gillis S, William DE (1987) Synergistic effects of purified recombinant human B cell growth factor-1/ Interleukin 4 on colony formation in vitro by human hematopoietic cells. Blood 70 (suppl 1): 525
Campbell HD, Tucker WQS, Hort Y, Martinson ME, Mayo G, Clutterbuck EJ, Sanderson CS, Young IG (1987) Molecular cloning and expression of the gene encoding human eosinophil differentiation factor (Interleukin-5). Proc Natl Acad Sci USA: 84: 6629
Lopez AF, Sanderson CJ, Gamble JR, Campbell HD, Young IG, Vadas MA (1988) Recombinant human interleukin-5 (IL-5) is a selective activator of human eosinophil function. J Exp Med 167: 219–24
Freeman G, Freedman A, Robinowe S, Segil J, Nadler LM (1987) Expression of IL-6 (BCDF) and IL-4 (BSF-1) genes in normal activated and neoplastic B cells. Blood 70 (suppl): 882
Sherr CJ, Rettenmier CW, Sacca R, Roussel MF, Look AT, Stanley ER (1985) The c-fms proto-oncogene product is related to the receptor for the mononuclear/phagocyte growtj factor CSF-1. Cell 41: 665–676
Le Beau MM, Westbrook CA, Diaz MO Larson RA, Rowley JD, Gasson JC, Golde DW, Sherr CJ (1986) Evidence for the involvement of GM-CSF and FMS in the deletion (5q) in myeloid disorders. Science 231: 984–987
Huebner K, Isobe M, Croce CM, Golde DW, Kaufmann SE, Gasson JC (1985) The human gene encoding GM-CSF is at 5q21–q32 the chromosome region deleted in the 5q- anomaly. Science 230: 1282–1285
Le Beau MM, Epstein ND, O’Brien SJ, Nienhuis AW, Yang YC, Clark SC, Rowley JD (1987) The interleukin 3 gene is located on human chromosome 5 and is deleted in myeloid leukemia with a deletion of 5q. Proc Natl Acad Sci (USA) 84: 5913–5917
Pettenati MJ, Le Beau MM, Lemons RS, Shima EA, Kawasaki ES, Larson RA, Sherr CJ, Diaz MO, Rowley JD (1987) Assignment of CSF1 to 5q33.1 evidence for clustering of genes regulating hematopoiesis and for their involvement in the deletion of the long arm of chromosome 5 in myeloid disorders. Proc Natl Acad Sci (USA): 84: 2970–2974
Sutherland GR, Baker E, Callen DF, Campbell HD, Young ID, Sanderson CS, Garson OM, Lopez AF, Vadas M (1988) Interleukin 5 is at 5q31 and is deleted in the 5q- syndrome., Blood 71: 1150–52
Yang Y-Chung, Kovacic S, Kriz R, Woll S, Clark SC, Wellens TE, Nienhuis A, Epstein N (1988) The human genes for GM-CSF and IL-3 are closely linked in tandem on chromosome 5. Blood 71: 958–961
Simmers RN, Webber LM, Shannon MF, Garson OM, Wong G, Vadas MA, Sutherland GR (1987) Localization of the G-CSF gene on chromosome 17 proximal to the breakpoint in the t (15, 17) in acute promyelocytic leukemia. Blood 70: 330–332
Broudy VC, Kaushansky K, Harlan JM, Adamson JW (1987) Interleukin 1 stimulates human endothelial cells to produce Granulocyte Macrophage colony-stimulating factor and granulocyte colony-stimulating factor. J Immunol 139: 464–468
Kaushansky K, Lin N, Adamson JW (1987) Interleukin 1 stimulates fibroblasts to synthesize granulocyte-macrophage and granulocyte colony-stimulating factor. J Clin Invest 81: 92–97
Kaushansky K, Miller JE, Morris DR, Hammond WP (1986) Hematopoietic growth factors (HGF) derived from human peripheral blood mononuclear cells (MNC): Evidence for dependant production by purified lymphocytes (Lymphs) and monocytes (monos). Blood 68 (suppl): 549
Metcalf D (1987) The role of the colony stimulating factors in resistance to acute infection. Immunol Cell Biol 65: 35–43
Welte K, Platzer E, Lu L, Gabrilove JC, Levi E, Mertelsmann R, Moore MAS (1985) Purification and biochemical characterization of human pluripotent hematopoietic colony stimulating factor. Proc Natl Acad Sci (USA) 82: 1526
Souza LM, Boone TC, Gabrilove JL, Lai PH, Zsebo KN, Murdock DC, Chazin VR, Bruszewski J, Lu L, Chen KK, Burendt J, Platzer E, Moore MAS, Mentelsmann R, Welfe K (1986) Recombinant human granulocyte colony stimulating factor: Effects on normal and leukemic myeloid cells. Science 232: 61
Nagata S, Tsuchiya M, Asano S, Kazino Y, Yamazaki T, Yamamoto O, Hirata Y, Kubota N, Oheda M, Nomura H, Ono M (1986) Molecular cloning and expression of cDNA for human granulocyte colony stimulating factor. Nature 319: 415
Clark SC, Kamen R (1987) The human hematopoietic factors. Science 236: 1229–36
Platzer E, Welfe K, Gabrilove J, Lu E, Harris P, Mentelsmann R, Moore MAS (1986) Biological activities of human pluripotent hemopoietic colony stimulating factor on normal and leukemic cells. J Exp Med 162: 1788–1801
Platzer E, Ocz S, Welfe K, Gabrilove JL, Mentelsmann R, Moore MAS, Kalder JR (1986) Human pluripotent hemopoietic colony stimulating factor: Activities on human and marine cells. Immuno Biol 172: 185
Avalos BR, Hedzat C, Baldwin GC, Golde DW, Gasson JC, DiPersio JF (1987) Biological activities of human G-CSF and characterization of the human G-CSF receptor. Blood 70 (suppl): 517
Welte K, Bonilla MA, Gabrilove JL, Gillio AP, Potter GK, Moore MAS, O’Reilly RJ, Boone TC, Souza LM (1987) Recombinant human granulocyte-colony stimulating factor: in vitro and in vivo effects on myelopoiesis. Blood Cells 13: 17–30
Cohen AM, Zsebo KM, Inove H, Hines D, Boone TL, Chazin VR, Tsai L, Ritch T, Souza L (1987) In vivo stimulation of granulopoiesis by recombinant human granulocyte colony-stimulating factor. Proc Natl Acad Sci (USA) 84: 2484–2488
Welte K, Bonilla MA, Gillio AP, Boone TC, Kotter GK, Gabrilove JL, Moore MAS, O’Reilly RJ, Souza LM (1987) Recombinant human granulocyte colony-stimulating factor. Effects on hematopoiesis in normal and cyclophosphamide-treated primates. J Exp Med 165: 941
Shimamura M, Kobayashi Y, Yuo A, Urabe A, Okabe T, Komatsu Y, Itoh S, Takaku F (1987) Effect of human recombinant granulocyte colony-stimulating factor on hematopoietic injury in mice induced by 5 fluorouracil. Blood 69: 353–355
Bonilla MA, Gillio AP, Potter GK, O’Reilly RJ, Souza LM, Welfe K (1987) Effects of recombinant human G-CSF and GM-CSF on cytopenias associated with repeated cycles of chemotherapy in primates. Blood 70 (suppl): 377
Gabrilove JL, Jakubowski A, Scher H, Sternberg C, Wong G, Grous J, Yagoda A, Fain K, Moore MAS, Clarkson B, Oettgen HF, Alton K, Welfe K Souza L (1988) Effect of granulocyte colony-stimulating factor on neutropenia and associated morbidity due to chemotherapy for transitional cell carcinoma of the urothelium. New Engl J Med 318: 1414–1422
Chikkappa G, Wong G, Santella D, Pasquale D (1987) Neutrophil Alkaline Phosphatase (NAP) synthesis is regulated by Granulocyte colony-stimulating factor (G-CSF). Blood 70 (suppl): 195
Bronchud MH, Scarffe JH, Thatcher N, Crowther Dm, Souza LM, Alton NK, Testa NG, Dexter TM (1987) Phase 1/11 study of recombinant human granulocyte colony-stimulating factor in patients receiving intensive chemotherapy for small cell lung cancer. Br J Cancer 56: 809–813
Bronchud M, Potter MR, Morgenstern G, Blasco MJ, Scarffe JH, Thatcher, Crowther D, Souza LM, Alton NK, Testa NG, Dexter TM (1988, in press) In vitro and in vivo analysis of the effects of recombinant human granulocyte colony-stimulating factor in patients. Br J Cancer 58
Morstyn G, Campbell L, Souza LM, Alton NK, Keech J, Green M, Sheridan W, Metcalf D, Fox R (1988) Effect of granulocyte colony stimulating factor on neutropenia induced by cytotoxic chemotherapy. Lancet 667–671
Spitzer G, Dicke KA, Litam J, Verma DS, Zander A, Lanzotti V, Valdivieso M, McCredie K, Samuels ML (1980) High-dose combination chemotherapy with autologous bone marrow transplantation in adult solid tumors. Cancer 45: 3075–85
Jagannath S, Dicke KA, Armitage JO, Cabanillas F, Horwitz LJ, Vellekoop L, Zander AR, Spitzer G (1986) High dose cyclophosphamide, carmustine and etoposide and autologous bone marrow transplantation for relapsed Hodgkin’s disease. Ann Intern Med 104: 163
Taylor K McD, Spitzer G, Dicke KA, Cabanillas F, Horwitz LJ, Vincent M, Jagannath S, Souza L (1988, in preparation) Recombinant human granulocyte-colony stimulating factor hastens granulocyte recovery in Hodgkin’s disease after high dose chemotherapy and autologous bone marrow transplantation (ABMT)
Lothrop GD, Jones JB, Warren DJ, Moore MAS Souza LM (1987) Correction of cyclic hematopoiesis with recombinant human granulocyte colony-stimulating factor. Blood 70 (suppl): 407
Nagler A, Ginzton N, Bungs C, Donlon T, Greenberg PL (1987) In vitro effects of recombinant human (rh) granulocyte (G-CSF) and granulocyte-monocyte (GM-CSF) colony stimulating factors on hemopoiesis in the myelodysplastic syndromes. Blood 70 (suppl): 417
Yuo A, Kitagawa S, Okabe T, Urabe A, Komatsu Y, Hoh S Takaku F (1987) Recombinant human granulocyte colony-stimulating factor repairs the abnormalities of neutrophils in patients with myelodysplastic syndromes and chronic myelogenous leukemia. Blood 70: 404–411
Negrin RS, Haeuber DH, Nagler A, Souza LM, Greenberg PL (1988) Treatment of myelodysplastic syndromes with recombinant human granulocyte colony stimulating factor. Exp Hematol 16 (suppl): 240
Bonilla MA, Gillio AP, Ruggiero M, Kernan NA, Brochstein JA, Fumagalli L, Bordignon C, Vincent M, Welte K, Souza L, O’Reilly RJ (1988) Correction of neutropenia in patients with congenital agranulocytosis with recombinant human granulocyte colony stimulating factor in vivo. Exp Hematol 16 (suppl): 243
Lotze MT, Matory YL, Rayner AA, Ettinghauser SE (1986) Clinical effects and toxicity of Interleukin-2 in patients with cancer. Cancer 58: 2764–2772
Rosenstein M, Ettinghausen SE, Rosenberg SA (1986) Extravasation of intravascular fluid mediated by the systemic administration of recombinant Interleukin 2. J Immunol 137: 1735–1742
Brandt SJ, Peters WP, Atwater SK, Kurtzberg J, Borowitz MJ, Jones RB, Shpall EJ, Bart RC, Gilbert CJ, Oettte DH (1988) Effect of recombinant human granulocyte-macrophage colony stimulating factor or Hematopoietic reconstitution after high dose chemotherapy and autologous bone marrow transplantation. New Engl J Med 318: 869–875
Wheeler JG, Chauveret AR, Johnson CA, Dillard R, Block SM, Boyle R, Abramson JS (1984) Neutrophil storage pool depletion in septic neutropenic neonates. Pediatr Infect Dis 3: 407–409
Christensen RD, Rothstein G, Anstall HB and Bykee B (1982) Granulocyte transfusions in neonates with bacterial infection, neutropenia and depletion of mature marrow neutrophils. Paediatrics 70: 1–6
Cairns MS, Worchester C, Rucker R, Bennetts GA, Anlie R, Perkin R, Anas N, Hicks D (1987) Role of circulating complement and polymorphonuclear leukocyte transfusion in treatment and outcome in critically ill neonates with sepsis. J Pediatr 110: 935–41
Nicola NA, Begley CG, Metcalf D (1985) Identification of the human analoque differentiation in murine leukaemic cells. Nature 314: 625–628
Begley CG, Metcalf D, Nicola NA (1987) Primary human myeloid leukaemia cells: comparative responsiveness to proliferative stimulation by GM-CSF or G-CSF and membrane expression of CSF receptors. Leukarmia 1: 1–8
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1989 Springer Science+Business Media New York
About this paper
Cite this paper
Taylor, K.M., Spitzer, G., Souza, L. (1989). Granulocyte Colony-Stimulating Factor. In: Baum, S.J., Dicke, K.A., Lotzová, E., Pluznik, D.H. (eds) Experimental Hematology Today—1988. Experimental Hematology Today—1988, vol 1988. Springer, New York, NY. https://doi.org/10.1007/978-1-4613-8862-3_9
Download citation
DOI: https://doi.org/10.1007/978-1-4613-8862-3_9
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4613-8864-7
Online ISBN: 978-1-4613-8862-3
eBook Packages: Springer Book Archive